Selected Grants
Discovering the cell type basis of the IT projection system and its dysregulation after perinatal HIE
ResearchCo-Mentor · Awarded by National Institutes of Health · 2024 - 2029Research Training in Allergy and Clinical Immunology
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2000 - 2025Characterizing the oxysterol, 20-hydroxycholesterol, as a mediator of remyelination in multiple sclerosis
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2021 - 2024Mechanisms of oxysterol-induced oligodendrogenesis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2019 - 2024Disruption of oligodendrogenesis following sepsis-induced injury to the postnatal subventricular zone
ResearchPrincipal Investigator · Awarded by American Academy of Pediatrics · 2021 - 2023Study on innate immune inflammation that enhances EAE
ResearchCollaborator · Awarded by National Multiple Sclerosis Society · 2011 - 2022Therapeutic Potential of Oxysterols in Neonatal White Matter Injury
FellowshipPrincipal Investigator · Awarded by American Academy of Pediatrics · 2020 - 2022Duke Research Training Program for Pediatricians
Inst. Training Prgm or CMETraining Faculty · Awarded by National Institutes of Health · 2002 - 2018External Relationships
- Tellus Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.